The positions in the table below reflect the Escient Pharmaceuticals's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to ...

Escient Pharmaceuticals, known for its commitment to pioneering research and development in neurosensory and immune systems treatment medicine, recognizes the importance of staying at the forefront of ...

Escient Pharmaceuticals launched today with $40 million in series A funding to develop small-molecule inhibitors of an unusual class of G protein-coupled receptors (GPCRs) implicated in chronic ...